VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1691532
Sex: F
Age: 69
State: TX

Vax Date: 12/31/2020
Onset Date: 02/01/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Rash broke out on both Legs, Back, and Left shoulder after the second dose; She broke out on both legs and left shoulder injection site 2 weeks after the second shot; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash broke out on both Legs, Back, and Left shoulder after the second dose) and VACCINATION SITE RASH (She broke out on both legs and left shoulder injection site 2 weeks after the second shot) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 025L20A) for COVID-19 vaccination. No Medical History information was reported. Concomitant products included CELECOXIB (CELEBREX) for an unknown indication. On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced RASH (Rash broke out on both Legs, Back, and Left shoulder after the second dose) and VACCINATION SITE RASH (She broke out on both legs and left shoulder injection site 2 weeks after the second shot). The patient was treated with BETAMETHASONE for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH (Rash broke out on both Legs, Back, and Left shoulder after the second dose) and VACCINATION SITE RASH (She broke out on both legs and left shoulder injection site 2 weeks after the second shot) outcome was unknown. The patient was taking Celebrex and stopped the use of Celebrex to see if that improves the rash, but the rash was not recovered. This case was linked to MOD-2021-296638 (Patient Link).

Other Meds: CELEBREX

Current Illness:

ID: 1691533
Sex: M
Age:
State:

Vax Date: 06/23/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Experienced anxiety while driving; Generally he does not feel good; A little bit of blurred vision; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Experienced anxiety while driving), FEELING ABNORMAL (Generally he does not feel good) and VISION BLURRED (A little bit of blurred vision) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANXIETY (Experienced anxiety while driving), FEELING ABNORMAL (Generally he does not feel good) and VISION BLURRED (A little bit of blurred vision). At the time of the report, ANXIETY (Experienced anxiety while driving), FEELING ABNORMAL (Generally he does not feel good) and VISION BLURRED (A little bit of blurred vision) outcome was unknown. No concomitant and treatment information were reported by the reporter.

Other Meds:

Current Illness:

ID: 1691534
Sex: F
Age: 61
State: MT

Vax Date: 02/11/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: didn't feel well; broke out in a rash entirely all over my body /Rash was like little bumps underneath the skin, everywhere; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (didn't feel well) and RASH (broke out in a rash entirely all over my body /Rash was like little bumps underneath the skin, everywhere) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The patient's past medical history included Hay fever and Urticaria (Hives). Concurrent medical conditions included Blood pressure high since 2015, GERD since 2008, Asthma, Penicillin allergy and Drug allergy (Sulfa). Concomitant products included LISINOPRIL, DEXLANSOPRAZOLE (DEXILANT) from 06-Jan-2008 to an unknown date, LEVOTHYROXINE SODIUM (SYNTHROID) and LEVOTHYROXINE for an unknown indication. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (didn't feel well) and RASH (broke out in a rash entirely all over my body /Rash was like little bumps underneath the skin, everywhere). The patient was treated with HYDROCHLOROTHIAZIDE (oral) at a dose of 12.5 mg daily. At the time of the report, VACCINATION COMPLICATION (didn't feel well) and RASH (broke out in a rash entirely all over my body /Rash was like little bumps underneath the skin, everywhere) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Directions for first dose were not provided. This case was linked to MOD-2021-296654, MOD-2021-296286 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 31-Aug-2021: Significant Follow up updated patient history.

Other Meds: LISINOPRIL; DEXILANT; SYNTHROID; LEVOTHYROXINE

Current Illness: Asthma; Blood pressure high; Drug allergy (Sulfa); GERD; Penicillin allergy

ID: 1691535
Sex: F
Age: 42
State: OH

Vax Date: 03/18/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Weak; Really sick; Arm did hurt like a fracture; Loosing sensation for taste; Loosing sensation for smell; Extremely tired; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak), ILLNESS (Really sick), PAIN IN EXTREMITY (Arm did hurt like a fracture), AGEUSIA (Loosing sensation for taste) and ANOSMIA (Loosing sensation for smell) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weak), ILLNESS (Really sick), PAIN IN EXTREMITY (Arm did hurt like a fracture), AGEUSIA (Loosing sensation for taste), ANOSMIA (Loosing sensation for smell), FATIGUE (Extremely tired) and PYREXIA (Fever). At the time of the report, ASTHENIA (Weak), ILLNESS (Really sick), PAIN IN EXTREMITY (Arm did hurt like a fracture), AGEUSIA (Loosing sensation for taste), ANOSMIA (Loosing sensation for smell), FATIGUE (Extremely tired) and PYREXIA (Fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant product use was provided by the reporter. No treatment medication was provided. This case was linked to MOD-2021-296660 (Patient Link).

Other Meds:

Current Illness:

ID: 1691536
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: missed his second Moderna vaccine due to cardiac surgery; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed his second Moderna vaccine due to cardiac surgery) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Surgery. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed his second Moderna vaccine due to cardiac surgery). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed his second Moderna vaccine due to cardiac surgery) outcome was unknown. No concomitant medications reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1691537
Sex: M
Age: 68
State: NY

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: weakness; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), HEADACHE (Headache) and PYREXIA (Fever) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ASTHENIA (weakness), HEADACHE (Headache) and PYREXIA (Fever). On 24-Jan-2021, ASTHENIA (weakness), HEADACHE (Headache) and PYREXIA (Fever) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-297468 (Patient Link).

Other Meds:

Current Illness:

ID: 1691538
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Electrocardiogram; Result Unstructured Data: normal

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Heart pains; Painful flare ups; Weird Tissue pains in Arms and Leg, left arm pain; Issues getting full breathing ability; Vision impaired; Weirdnesses/really strange; Blurred vision/lots of Blurred sporadically Visionary issues; Chest pain, piercing pain through and wrapping around my left side of the chest,; Skin in spots on both arms feeling like sand-paper; Low back pain; Right knee got so sore and swollen; My right knee got so sore and swollen that I could barely walk on it; Nerve pain; soreness in bones in arms; Soreness in the skin tissue and actually in the Bones in my Arms and the muscle tissue, muscle pain; This spontaneous case was reported by an other health care professional and describes the occurrence of ANGINA PECTORIS (Heart pains) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Co-suspect product included non-company product INFLUENZA VACCINE (FLU SYRINGE) for Influenza. The patient's past medical history included Back surgery (Botched back surgery couple years ago). Concurrent medical conditions included COPD. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. and INFLUENZA VACCINE (FLU SYRINGE) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ANGINA PECTORIS (Heart pains) (seriousness criterion medically significant), PAIN (Painful flare ups), PAIN IN EXTREMITY (Weird Tissue pains in Arms and Leg, left arm pain), DYSPNOEA (Issues getting full breathing ability), VISUAL IMPAIRMENT (Vision impaired), FEELING ABNORMAL (Weirdnesses/really strange), VISION BLURRED (Blurred vision/lots of Blurred sporadically Visionary issues), CHEST PAIN (Chest pain, piercing pain through and wrapping around my left side of the chest,), RASH (Skin in spots on both arms feeling like sand-paper), BACK PAIN (Low back pain), JOINT SWELLING (Right knee got so sore and swollen), GAIT DISTURBANCE (My right knee got so sore and swollen that I could barely walk on it), NEURALGIA (Nerve pain) and MYALGIA (Soreness in the skin tissue and actually in the Bones in my Arms and the muscle tissue, muscle pain). At the time of the report, ANGINA PECTORIS (Heart pains), PAIN (Painful flare ups), PAIN IN EXTREMITY (Weird Tissue pains in Arms and Leg, left arm pain), DYSPNOEA (Issues getting full breathing ability), VISUAL IMPAIRMENT (Vision impaired), FEELING ABNORMAL (Weirdnesses/really strange), VISION BLURRED (Blurred vision/lots of Blurred sporadically Visionary issues), CHEST PAIN (Chest pain, piercing pain through and wrapping around my left side of the chest,), RASH (Skin in spots on both arms feeling like sand-paper), BACK PAIN (Low back pain), JOINT SWELLING (Right knee got so sore and swollen), GAIT DISTURBANCE (My right knee got so sore and swollen that I could barely walk on it), NEURALGIA (Nerve pain) and MYALGIA (Soreness in the skin tissue and actually in the Bones in my Arms and the muscle tissue, muscle pain) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Electrocardiogram: normal (normal) normal. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The patient stated that he/she got flu shot six months after Second shot of Moderna, and in 30-45 minutes, developed vision impaired, chest pain and some issues. The patient stated that he/she had noticed Skin in spots on both arms feeling like sandpaper, about day 10 after the second shot, along with blurry vision sporadically. He/she had soreness in the skin tissue and actually in the bones, in the arms, and the muscle tissue, and then some e lower back pain. The patient stated that he/she had right knee soreness and swollen that they could barely walk on it. The patient also stated that he/she had a Couple trips to ER visits with chest pains and a piercing pain through and wrapping around the left side of the chest, and also left arm pain. Concomitant product was not provided by the reporter. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2021: Follow up received contains significant information-History updated and events added. On 03-Sep-2021: Follow-up received: Lab data added. Vaccine information updated. New events- Skin rash, Myalgia, Back pain, Joint swelling, Gait disturbance, and Neuralgia added.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness: COPD

ID: 1691539
Sex: M
Age:
State: NY

Vax Date: 05/21/2021
Onset Date: 05/21/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: son didn't receive second shot / Beyond 35 days for 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (son didn't receive second shot / Beyond 35 days for 2nd dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination. No Medical History information was reported. On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (son didn't receive second shot / Beyond 35 days for 2nd dose). On 21-May-2021, PRODUCT DOSE OMISSION ISSUE (son didn't receive second shot / Beyond 35 days for 2nd dose) had resolved. No concomitant medications were provided by reporter. No treatment medications were provided by reporter. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 26-Aug-2021: Follow up received , Product lot number added.

Other Meds:

Current Illness:

ID: 1691540
Sex: M
Age:
State: NM

Vax Date: 03/08/2021
Onset Date: 08/24/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: swelling; Interfere with motion; Pain under arm pit; Migraine with vomiting; Migraine with vomiting; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine with vomiting), SWELLING (swelling), HYPOKINESIA (Interfere with motion), VOMITING (Migraine with vomiting) and AXILLARY PAIN (Pain under arm pit) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004F21A, 016B21A and 029A21A) for COVID-19 vaccination. Concurrent medical conditions included Psoriatic arthritis. Concomitant products included ADALIMUMAB (HUMIRA) for an unknown indication. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2021, the patient experienced MIGRAINE (Migraine with vomiting) and VOMITING (Migraine with vomiting). On 25-Aug-2021, the patient experienced SWELLING (swelling), HYPOKINESIA (Interfere with motion) and AXILLARY PAIN (Pain under arm pit). At the time of the report, MIGRAINE (Migraine with vomiting), SWELLING (swelling), HYPOKINESIA (Interfere with motion), VOMITING (Migraine with vomiting) and AXILLARY PAIN (Pain under arm pit) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment medication were provided. Patient said that he would provide ultra sound data to Moderna, but Modena would have to follow-up with him.

Other Meds: HUMIRA

Current Illness: Psoriatic arthritis

ID: 1691541
Sex: F
Age:
State: FL

Vax Date:
Onset Date: 08/07/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: There are big bumps. They are swelling up; Itching; Looked as if she had shingles; Body is "not well"; Body began to ache/Felt like "when bees bite you, all over my body"; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (There are big bumps. They are swelling up), PRURITUS (Itching), HERPES ZOSTER (Looked as if she had shingles), MALAISE (Body is "not well") and MYALGIA (Body began to ache/Felt like "when bees bite you, all over my body") in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Aug-2021, the patient experienced SWELLING (There are big bumps. They are swelling up), PRURITUS (Itching), HERPES ZOSTER (Looked as if she had shingles), MALAISE (Body is "not well") and MYALGIA (Body began to ache/Felt like "when bees bite you, all over my body"). At the time of the report, SWELLING (There are big bumps. They are swelling up), PRURITUS (Itching), HERPES ZOSTER (Looked as if she had shingles), MALAISE (Body is "not well") and MYALGIA (Body began to ache/Felt like "when bees bite you, all over my body") outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1691542
Sex: M
Age: 22
State: MA

Vax Date: 06/02/2021
Onset Date: 06/02/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210603; Test Name: blood pressure; Result Unstructured Data: High at 160/100 and remained so for a month; Test Date: 20210611; Test Name: blood pressure; Result Unstructured Data: 180/116; Test Date: 20210603; Test Name: Blood work; Result Unstructured Data: normal; Test Date: 20210603; Test Name: EKG; Result Unstructured Data: Normal; Test Date: 20210611; Test Name: EKG; Result Unstructured Data: normal

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: anxiety; blood pressure was high; really tired; felt chest pressure; fast heartbeat; This spontaneous case was reported by a nurse and describes the occurrence of ANXIETY (anxiety), CHEST DISCOMFORT (felt chest pressure), HEART RATE INCREASED (fast heartbeat), HYPERTENSION (blood pressure was high) and FATIGUE (really tired) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jun-2021, the patient experienced CHEST DISCOMFORT (felt chest pressure), HEART RATE INCREASED (fast heartbeat) and FATIGUE (really tired). On 03-Jun-2021, the patient experienced HYPERTENSION (blood pressure was high). On an unknown date, the patient experienced ANXIETY (anxiety). The patient was treated with DIAZEPAM (VALIUM) for Anxiety, at an unspecified dose and frequency. On 15-Jun-2021, CHEST DISCOMFORT (felt chest pressure) and HEART RATE INCREASED (fast heartbeat) had resolved. In July 2021, HYPERTENSION (blood pressure was high) had resolved. At the time of the report, ANXIETY (anxiety) and FATIGUE (really tired) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Jun-2021, Blood pressure measurement: 160/100 (High) High at 160/100 and remained so for a month. On 03-Jun-2021, Blood test: normal (normal) normal. On 03-Jun-2021, Electrocardiogram: normal (normal) Normal. On 11-Jun-2021, Blood pressure measurement: 180/116 (High) 180/116. On 11-Jun-2021, Electrocardiogram: normal (normal) normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The concomitant medication was not reported. On 13/Aug/2021, Patient had a stress test, Holter Monitor, and echogram performed and did not yet receive the results. Patient had another cardiology appointment in Sep/2021. Patient did not consistently take treatment medication Valium for anxiety and stopped the medication as he did not like how it made him feel.

Other Meds:

Current Illness:

ID: 1691543
Sex: M
Age: 78
State: NJ

Vax Date: 01/21/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: very mild malaise type of feeling; Soreness at the injection site; feeling of tiredness; This spontaneous case was reported by a pharmacist and describes the occurrence of MALAISE (very mild malaise type of feeling), VACCINATION SITE PAIN (Soreness at the injection site) and FATIGUE (feeling of tiredness) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 025J20A OR 02C120A) for COVID-19 vaccination. Concurrent medical conditions included Hypothyroidism, Hypertension (High Blood Pressuer), BPH, Sleep apnea and Atrial fibrillation. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), APIXABAN (ELIQUIS), FLECAINIDE, AMLODIPINE BESILATE (NORVASC), TADALAFIL (CIALIS), HYDROCHLOROTHIAZIDE and NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for an unknown indication. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (very mild malaise type of feeling) and FATIGUE (feeling of tiredness). an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). The patient was treated with HYDROCORTISONE for Adverse event, at a dose of 1 dosage form. At the time of the report, MALAISE (very mild malaise type of feeling) and FATIGUE (feeling of tiredness) outcome was unknown and VACCINATION SITE PAIN (Soreness at the injection site) was resolving. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient took Dose-3 on 25-AUG-2021 and he had experience Hot, typical covid arm,giving him a little bit of problem. On 26-AUG-2021 he felt much better than 25-AUG-2021 and later itchiness and soreness is much better but the swelling and redness is a little bit better or the same. Other Treatment medicine: CBD Cream. This case was linked to MOD-2021-297029, MOD-2021-297099 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 27-Aug-2021: Follow up received contains no new information.

Other Meds: SYNTHROID; ELIQUIS; FLECAINIDE; NORVASC; CIALIS; HYDROCHLOROTHIAZIDE; BYSTOLIC

Current Illness: Atrial fibrillation; BPH; Hypertension (High Blood Pressuer); Sleep apnea

ID: 1691544
Sex: F
Age: 77
State: IA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. Concurrent medical conditions included Crohn's disease, Penicillin allergy, Sulfonamide allergy (Allergic to Sulfa drugs), Food allergy (Allergic to corn products and Mt Dew.), Drug allergy (Allergic to Ilosone), Drug allergy (Allergic to Cipro), Drug allergy (Allergic to Avelox), Drug allergy (Allergic to Valtrex), Drug allergy (Allergic to Flagyl) and Drug allergy (Allergic to Dacyclomins). Concomitant products included DIAZEPAM from 1977 to an unknown date and IMIPRAMINE HCL from 1977 to an unknown date for Agoraphobia, MESALAZINE (PENTASA) for Crohn's disease, CALCIUM CITRATE, COLECALCIFEROL (CALCIUM + VITAMIN D [CALCIUM CITRATE;COLECALCIFEROL]) and ASCORBIC ACID (ESTER C [ASCORBIC ACID]) for an unknown indication. On 20-Jan-2021 at 9:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Sore arm). On 20-Jan-2021, PAIN IN EXTREMITY (Sore arm) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The consumer stated that she has been using pentasa drug, 3 or 2 times per day, for Crohn's disease, since 2 or 3 years. Treatment information was not provided. This case was linked to MOD-2021-114492 (Patient Link).

Other Meds: DIAZEPAM; IMIPRAMINE HCL; CALCIUM + VITAMIN D [CALCIUM CITRATE;COLECALCIFEROL]; ESTER C [ASCORBIC ACID]; PENTASA

Current Illness: Crohn's disease; Drug allergy (Allergic to Valtrex); Drug allergy (Allergic to Ilosone); Drug allergy (Allergic to Flagyl); Drug allergy (Allergic to Dacyclomins); Drug allergy (Allergic to Cipro); Drug allergy (Allergic to Avelox); Food allergy (Allergic to corn products and Mt Dew.); Penicillin allergy; Sulfonamide allergy (Allergic to Sulfa drugs)

ID: 1691545
Sex: M
Age: 67
State: GA

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: "Typical bad reactions"; Low grade fever; General fatigue; Received 50mcg IM injection (Half dose); 3rd dose received after 28 days of second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION ("Typical bad reactions"), PYREXIA (Low grade fever), FATIGUE (General fatigue), ACCIDENTAL UNDERDOSE (Received 50mcg IM injection (Half dose)) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd dose received after 28 days of second dose) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 8520100102) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 50 microgram. On 28-Jan-2021, the patient experienced VACCINATION COMPLICATION ("Typical bad reactions"), PYREXIA (Low grade fever), FATIGUE (General fatigue), ACCIDENTAL UNDERDOSE (Received 50mcg IM injection (Half dose)) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd dose received after 28 days of second dose). On 28-Jan-2021, ACCIDENTAL UNDERDOSE (Received 50mcg IM injection (Half dose)) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd dose received after 28 days of second dose) had resolved. On 29-Jan-2021, VACCINATION COMPLICATION ("Typical bad reactions"), PYREXIA (Low grade fever) and FATIGUE (General fatigue) had resolved. The consumer reported that he received a third booster dose, 50 mcg, of Moderna vaccine on 28Jan2021 and experienced the typical bad reactions, including low grade fever and general fatigue. He reported that the events lasted for 24 hours and resolved. No concomitant product use was provided by the reporter. No treatment medications were reported. The consumer stated that he was in the Moderna COVID-19 Phase 2 Clinical Trials. He stated that he was unblinded and did receive the actual Moderna COVID-19 vaccine and not the placebo. He stated that he received the first Moderna COVID-19 dose on 26 June 2020. He also stated that the intramuscular injection of dose 100 mcg was given into his left deltoid and lot number was 8520100102. The consumer stated he didn't experienced any adverse events after the first dose. The consumer reported that he received the second Moderna COVID-19 dose on 29 July 2021. He stated that he was given 100 mcg dose into the left deltoid, intramuscularly, and lot number was 8520100103. The consumer reported that after the second dose he experienced the typical bad reactions, including low grade fever and general fatigue. The consumer reported that the events lasted for 24 hours and resolved. The consumer reported that he was perfectly healthy and does not use any medications daily. He also stated that he probably gave blood 12 times during the clinical trial. Most recent FOLLOW-UP information incorporated above includes: On 26-Aug-2021: Follow up received includes added Patient's race, Second dose start date.

Other Meds:

Current Illness:

ID: 1691546
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/11/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Coronary angiography findings; Result Unstructured Data: No obstructive coronary artery disease; proximal circumflex; mild 30% stenosis; Test Name: Antinuclear antibody screen; Test Result: Negative ; Result Unstructured Data: Negative; Test Name: Blood pressure; Result Unstructured Data: at the time of presentation; Test Name: Temperature; Result Unstructured Data: at the time of presentation; Test Name: B-type natriuretic peptide; Result Unstructured Data: 97 pg/mL; Test Name: Chest x-ray findings; Result Unstructured Data: No detectable active cardiopulmonary disease; Test Name: C-reactive protein; Result Unstructured Data: 11.70 mg/dL (peak); Test Name: Echocardiogram; Result Unstructured Data: Intraventricular septal diastolic thickness (2D): 1.0 cm. Regional wall motion abnormalities: None Diastolic function: Normal (4 days postvaccine); Test Name: Cardiac magnetic resonance imaging (Left ventricular ejection fraction); Result Unstructured Data: 52%, no regional wall motion abnormalities (5 days postvaccine); Test Name: Echocardiogram (Left ventricular ejection fraction); Result Unstructured Data: 61% (4 days postvaccine); Test Name: ECG findings (ST changes and rhythm); Result Unstructured Data: No acute ST segment changes and normal sinus rhythm; Test Name: Heart rate; Result Unstructured Data: at the time of presentation; Test Name: Cardiac magnetic resonance imaging (T2); Result Unstructured Data: Suboptimal T2 WI secondary to banding artifact and respiratory motion (5 days postvaccine); Test Name: LGE (late gadolinium enhancement); Result Unstructured Data: Multifocal subepicardial and midmyocardial LGE; prominence of the pericardium overlying the anterior wall with enhancement (5 days postvaccine); Test Name: Erythrocyte sedimentation rate; Result Unstructured Data: 23 mm/h (peak); Test Name: Respirations; Result Unstructured Data: at the time of presentation; Test Name: Respiratory viral panel; Test Result: Negative ; Result Unstructured Data: Negative except mycoplasma IgG; Coxsackie B1, B2, B3 (IgG 1:8) and B4, B5, B6 (IgG 1:16) Respiratory viral panel was performed using the Respiratory Panel 2.1 and contains qualitative detection of respiratory pathogen nucleic acid for the following viruses: adenovirus, coronavirus 229E, coronavirus HKU1, coronavirus NL63, coronavirus OC43, SARS-CoV-2, human metapneumovirus, human rhinovirus/enterovirus, influenza A, influenza A/H1, influenza AH1 2009, influenza A/H3, influenza B, parainfluenza virus 1, parainfluenza virus 2, parainfluenza virus 3, parainfluenza virus 4, respiratory syncytial virus, Bordetella pertussis, Bordetella parapertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae.; Test Name: Spike IgG; Test Result: Positive ; Result Unstructured Data: Positive (performed using LIAISON SARS-CoV-2 S1/S2 IgG assay); Test Name: SARS-CoV-2 PCR test; Test Result: Negative ; Result Unstructured Data: The patient denied history of previous COVID-19 infection.; Test Name: Cardiac troponin I; Result Unstructured Data: 3.41 ng/mL (no

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Myocarditis-like illness; This literature-study case was reported in a literature article and describes the occurrence of MYOCARDITIS (Myocarditis-like illness) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. LITERATURE REFERENCE: Myocarditis temporally associated with COVID-19 vaccination. Circulation. 2021;144(6):502-5 No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYOCARDITIS (Myocarditis-like illness) (seriousness criteria hospitalization and medically significant). The patient was hospitalized for 3 days due to MYOCARDITIS. At the time of the report, MYOCARDITIS (Myocarditis-like illness) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Angiogram: normal (normal) No obstructive coronary artery disease; proximal circumflex; mild 30% stenosis. On an unknown date, Antinuclear antibody: negative (Negative) Negative. On an unknown date, Blood pressure measurement: 103/70 mm hg at the time of presentation. On an unknown date, Body temperature: 36.9 ?c (normal) at the time of presentation. On an unknown date, Brain natriuretic peptide: 97 pg/ml 97 pg/mL. On an unknown date, C-reactive protein: 11.70 mg/dl (High) 11.70 mg/dL (peak). On an unknown date, Chest X-ray: normal (normal) No detectable active cardiopulmonary disease. On an unknown date, Echocardiogram: 1.0 cm, none, normal (normal) Intraventricular septal diastolic thickness (2D): 1.0 cm. Regional wall motion abnormalities: None Diastolic function: Normal (4 days postvaccine). On an unknown date, Ejection fraction: 52% 52%, no regional wall motion abnormalities (5 days postvaccine) and 61% 61% (4 days postvaccine). On an unknown date, Electrocardiogram: normal (normal) No acute ST segment changes and normal sinus rhythm. On an unknown date, Heart rate: 79 bpm at the time of presentation. On an unknown date, Magnetic resonance imaging heart: abnormal (abnormal) Suboptimal T2 WI secondary to banding artifact and respiratory motion (5 days postvaccine) and abnormal (abnormal) Multifocal subepicardial and midmyocardial LGE; prominence of the pericardium overlying the anterior wall with enhancement (5 days postvaccine). On an unknown date, Red blood cell sedimentation rate: 23 mm/h (High) 23 mm/h (peak). On an unknown date, Respiratory rate: 16 per min at the time of presentation. On an unknown date, Respiratory viral panel: negative (Negative) Negative except mycoplasma IgG; Coxsackie B1, B2, B3 (IgG 1:8) and B4, B5, B6 (IgG 1:16) Respiratory viral panel was performed using the FilmArray BioFire Respiratory Panel 2.1 and contains qualitative detection of respiratory pathogen nucleic acid for the following viruses: adenovirus, coronavirus 229E, coronavirus HKU1, coronavirus NL63, coronavirus OC43, SARS-CoV-2, human metapneumovirus, human rhinovirus/enterovirus, influenza A, influenza A/H1, influenza AH1 2009, influenza A/H3, influenza B, parainfluenza virus 1, parainfluenza virus 2, parainfluenza virus 3, parainfluenza virus 4, respiratory syncytial virus, Bordetella pertussis, Bordetella parapertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae.. On an unknown date, SARS-CoV-2 antibody test: positive (Positive) Positive (performed using LIAISON SARS-CoV-2 S1/S2 IgG assay). On an unknown date, SARS-CoV-2 test: negative (Negative) The patient denied history of previous COVID-19 infection.. On an unknown date, Troponin I: 3.41 ng/ml (High) 3.41 ng/mL (normal: <0.04 ng/mL) at presentation, 13.00 ng/ml (High) 13.00 ng/mL (normal: <0.04 ng/mL) peak value and 0.037 ng/ml (normal) 0.037 ng/mL (normal: <0.04 ng/mL) postdischarge. On an unknown date, Ventricular internal diameter: 4.4 cm 4.4 cm (4 days postvaccine). On an unknown date, White blood cell count: 8.28 8.28 (5 days postvaccine). For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered MYOCARDITIS (Myocarditis-like illness) to be possibly related. Concomitant medications were not provided. The symptoms at the time of presentation included fever, chills, shortness of breath, and chest heaviness/pain symptoms. Days from administration to presentation was 4 days. The patient was hemodynamically stable and did not have a pericardial friction rub or rash, no evidence of obstructive coronary artery disease. Multifocal subepicardial late gadolinium enhancement was present. No palpitation was reported, and there was no evidence of sustained arrhythmias. No evidence of an active viral illness or autoimmune disease. The patient was treated with Intravenous (IV) steroids for 3 days.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1691547
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: got covid-19 around 3 weeks ago and became dealthly ill, lost their sense of taste and smell; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got covid-19 around 3 weeks ago and became dealthly ill, lost their sense of taste and smell) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included METOPROLOL for an unknown indication. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (got covid-19 around 3 weeks ago and became dealthly ill, lost their sense of taste and smell). At the time of the report, COVID-19 (got covid-19 around 3 weeks ago and became dealthly ill, lost their sense of taste and smell) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication was not provided. Treatment information was not reported. Patient had COVID -19 around 3 weeks ago. This case was linked to MOD-2021-297213 (Patient Link).

Other Meds: METOPROLOL

Current Illness:

ID: 1691548
Sex: M
Age: 72
State: FL

Vax Date: 02/10/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: Weight decreased; Result Unstructured Data: loss of 20lbs

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: no appetite; Because of this illness the patient's primary care doctor suggested that they had enough protection from the virus; dog tired,too tired to do anything; did not receive second shot in allowed time; Exposure to COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (no appetite), ILLNESS (Because of this illness the patient's primary care doctor suggested that they had enough protection from the virus), FATIGUE (dog tired,too tired to do anything), PRODUCT DOSE OMISSION ISSUE (did not receive second shot in allowed time) and EXPOSURE TO SARS-COV-2 (Exposure to COVID-19) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The patient's past medical history included COVID-19. Concomitant products included TAMSULOSIN, LORATADINE (LOMAX [LORATADINE]), VITAMINS NOS (DAILY VITAMINS) and ATORVASTATIN for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (no appetite), ILLNESS (Because of this illness the patient's primary care doctor suggested that they had enough protection from the virus), FATIGUE (dog tired,too tired to do anything), PRODUCT DOSE OMISSION ISSUE (did not receive second shot in allowed time) and EXPOSURE TO SARS-COV-2 (Exposure to COVID-19). At the time of the report, DECREASED APPETITE (no appetite), ILLNESS (Because of this illness the patient's primary care doctor suggested that they had enough protection from the virus), FATIGUE (dog tired,too tired to do anything) and EXPOSURE TO SARS-COV-2 (Exposure to COVID-19) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (did not receive second shot in allowed time) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Weight decreased: 20 (Low) loss of 20lbs. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant drug included Cotaught and Blood pressure medication. Treatment medication was not reported. Patient was exposed to their grandson who tested positive for COVID-19 the day after seeing them. Patient's primary care doctor suggested that they had enough protection from the virus and did not need to continue the vaccination series. They have not received the second dose at but patient was considering at the time of this report.

Other Meds: TAMSULOSIN; LOMAX [LORATADINE]; DAILY VITAMINS; ATORVASTATIN

Current Illness:

ID: 1691549
Sex: F
Age: 88
State: MI

Vax Date: 08/01/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: The rash as big blotchy red areas that itch; The rash as big blotchy red areas that itch; They are huge masses of red spots all over her body; The rash continued to spread all over the body from head to toe; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (The rash as big blotchy red areas that itch), RASH PRURITIC (The rash as big blotchy red areas that itch), RASH MACULAR (They are huge masses of red spots all over her body) and RASH (The rash continued to spread all over the body from head to toe) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091O21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (The rash as big blotchy red areas that itch), RASH PRURITIC (The rash as big blotchy red areas that itch), RASH MACULAR (They are huge masses of red spots all over her body) and RASH (The rash continued to spread all over the body from head to toe). The patient was treated with PREDNISONE for Rash, at an unspecified dose and frequency. At the time of the report, RASH MACULAR (The rash as big blotchy red areas that itch), RASH PRURITIC (The rash as big blotchy red areas that itch), RASH MACULAR (They are huge masses of red spots all over her body) and RASH (The rash continued to spread all over the body from head to toe) outcome was unknown. No concomitant medications were reported. Treatment Includes Prednisone Taper Therapy. This case was linked to MOD-2021-297311 (Patient Link).

Other Meds:

Current Illness:

ID: 1691550
Sex: M
Age: 56
State: FL

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: arm was very sore all night; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was very sore all night) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. No Medical History information was reported. On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm was very sore all night). At the time of the report, PAIN IN EXTREMITY (arm was very sore all night) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details were provided. No treatment information was mentioned. This case was linked to MOD-2021-297345.

Other Meds:

Current Illness:

ID: 1691551
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: some one tell me its create complication like elergic reation; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (some one tell me its create complication like elergic reation) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (some one tell me its create complication like elergic reation). At the time of the report, HYPERSENSITIVITY (some one tell me its create complication like elergic reation) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication was not provided Treatment information was not provided

Other Meds:

Current Illness:

ID: 1691552
Sex: M
Age: 50
State: MA

Vax Date: 04/01/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: little fatigued after first dose; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (little fatigued after first dose) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. Concurrent medical conditions included Atopic dermatitis (On hands, inside area of the elbow, lower back, inner upper thighs and backs of the knees. Significant improvement ~10-14 days after receiving the second dose of COVID-19 vaccine.) since March 2016, Eczema (mainly on the palms of their hands, on the inside of their elbows, on the back of knee, in the lower back and in the inguinal area, and inner thigh.) and Psoriasis. On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (little fatigued after first dose). The patient was treated with IBUPROFEN at a dose of 200 milligram, one pill. At the time of the report, FATIGUE (little fatigued after first dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product was not provided by the reporter. Patient experienced a positive side effect for atopic dermatitis, eczema and psoriasis, mainly on the palms of their hands, on the inside of their elbows, on the back of knee, in the lower back and in the inguinal area, and inner thigh. This case was linked to MOD-2021-297551 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: Follow up information included Patient demographic details and Current condition details.

Other Meds:

Current Illness: Atopic dermatitis (On hands, inside area of the elbow, lower back, inner upper thighs and backs of the knees. Significant improvement ~10-14 days after receiving the second dose of COVID-19 vaccine.); Eczema (mainly on the palms of their hands, on the inside of their elbows, on the back of knee, in the lower back and in the inguinal area, and inner thigh.); Psoriasis

ID: 1691553
Sex: F
Age:
State: TX

Vax Date: 08/24/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Joint pain; Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pain) and MYALGIA (Muscle ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 24-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Joint pain) and MYALGIA (Muscle ache). At the time of the report, ARTHRALGIA (Joint pain) and MYALGIA (Muscle ache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant product use was provided by the reporter. No treatment medication was provided. The patient was around a relative who might have exposed her to Covid-19 last weekend, she had herself done a home test which was negative.

Other Meds:

Current Illness:

ID: 1691554
Sex: F
Age:
State:

Vax Date: 01/01/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: 20 minutes after I was vaccinated I went through an allergic reaction; itching; hives later in the day; very minor breathing issues; semi lethargic state in functionality; safe to get a second vaccine as the response was minor; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (20 minutes after I was vaccinated I went through an allergic reaction), PRURITUS (itching), URTICARIA (hives later in the day), IRREGULAR BREATHING (very minor breathing issues) and LETHARGY (semi lethargic state in functionality) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (20 minutes after I was vaccinated I went through an allergic reaction), PRURITUS (itching), URTICARIA (hives later in the day), IRREGULAR BREATHING (very minor breathing issues), LETHARGY (semi lethargic state in functionality) and PRODUCT DOSE OMISSION ISSUE (safe to get a second vaccine as the response was minor). At the time of the report, HYPERSENSITIVITY (20 minutes after I was vaccinated I went through an allergic reaction), PRURITUS (itching), URTICARIA (hives later in the day), IRREGULAR BREATHING (very minor breathing issues) and LETHARGY (semi lethargic state in functionality) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (safe to get a second vaccine as the response was minor) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications was provided. No Treatment medications was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1691555
Sex: F
Age: 67
State: NY

Vax Date: 07/27/2021
Onset Date: 07/27/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: felt a little tired after her first vaccination; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (felt a little tired after her first vaccination) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination. No medical history was provided by the reporter. On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced FATIGUE (felt a little tired after her first vaccination). At the time of the report, FATIGUE (felt a little tired after her first vaccination) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1691556
Sex: F
Age: 57
State: AZ

Vax Date: 07/16/2021
Onset Date: 07/16/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: More than 36 days since first dose, has not received 2nd dose; Body aches; Feverish, but not elevated; Headache; Within 15 minutes, moderate itching all over body; Developed hives/5 hives; Slight itching in the back of the throat; Mild tongue swelling; Mild swelling of lips and throat; Mild swelling of lips and throat; Aches and pains; Felt like her wrists and ankles were sprained; Acute allergic reaction to the first dose of the vaccine; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Within 15 minutes, moderate itching all over body), URTICARIA (Developed hives/5 hives), THROAT IRRITATION (Slight itching in the back of the throat), SWOLLEN TONGUE (Mild tongue swelling) and LIP SWELLING (Mild swelling of lips and throat) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Hypertension and Hypothyroidism. Concomitant products included AMLODIPINE for Hypertension, THYROID (ARMOUR THYROID) for Hypothyroidism. On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jul-2021, the patient experienced PRURITUS (Within 15 minutes, moderate itching all over body), URTICARIA (Developed hives/5 hives), THROAT IRRITATION (Slight itching in the back of the throat), SWOLLEN TONGUE (Mild tongue swelling), LIP SWELLING (Mild swelling of lips and throat), PHARYNGEAL SWELLING (Mild swelling of lips and throat), PAIN (Aches and pains), LIGAMENT SPRAIN (Felt like her wrists and ankles were sprained), HYPERSENSITIVITY (Acute allergic reaction to the first dose of the vaccine), INFLUENZA LIKE ILLNESS (Flu like symptoms), MYALGIA (Body aches), PYREXIA (Feverish, but not elevated) and HEADACHE (Headache). On 19-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 36 days since first dose, has not received 2nd dose). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency. In July 2021, PRURITUS (Within 15 minutes, moderate itching all over body), URTICARIA (Developed hives/5 hives), THROAT IRRITATION (Slight itching in the back of the throat), SWOLLEN TONGUE (Mild tongue swelling), LIP SWELLING (Mild swelling of lips and throat), PHARYNGEAL SWELLING (Mild swelling of lips and throat), PAIN (Aches and pains), LIGAMENT SPRAIN (Felt like her wrists and ankles were sprained), HYPERSENSITIVITY (Acute allergic reaction to the first dose of the vaccine), INFLUENZA LIKE ILLNESS (Flu like symptoms), MYALGIA (Body aches), PYREXIA (Feverish, but not elevated) and HEADACHE (Headache) had resolved. On 19-Aug-2021, PRODUCT DOSE OMISSION ISSUE (More than 36 days since first dose, has not received 2nd dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient stated that the events were mild that she did not feel any obstruction nor did she feel that her breathing was impaired. On 19 Aug 2021, she was scheduled for second dose and her physician said that he could not give the second dose because of the acute allergic reaction she experienced from the first dose, though patient said that it was non anaphylactic reaction. Physician recommended to get Johnson vaccine but patient did not want to get it. Patient stated that the allergist also recommended not to take dose-2 Moderna Vaccine, but when the patient is adamant to get the second dose, allergist recommended to get hospitalized in case needs treatment for a reaction. Patient took Aspirin for a few days, then she for breakthrough bleeding so she stopped it.

Other Meds: AMLODIPINE; ARMOUR THYROID

Current Illness: Hypertension; Hypothyroidism

ID: 1691557
Sex: M
Age:
State:

Vax Date: 01/16/2021
Onset Date: 08/24/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: received an expired booster dose; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received an expired booster dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017621A, 028L20A and 039K20A) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received an expired booster dose). 24-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 24-Aug-2021, EXPIRED PRODUCT ADMINISTERED (received an expired booster dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. No concomitant medications were reported. No treatment details were reported.

Other Meds:

Current Illness:

ID: 1691558
Sex: F
Age: 78
State: PA

Vax Date: 05/15/2021
Onset Date: 08/01/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210808; Test Name: X-ray; Result Unstructured Data: normal

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Fell out of the sofa onto the floor; Had to crawled because I couldn't lift myself up, was on the floor from Friday to Sunday; Diarrhea; Weakness; Dizziness, still dizzy; First shot on 15 May2021 and Second shot on 05 Aug2021; Right arm was swollen; Right arm was red; Really tired; It hurt when the needle entered; Vertigo; Weakness in legs; Muscles between the knees and ankles are tight; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), DIZZINESS (Dizziness, still dizzy), MUSCLE TIGHTNESS (Muscles between the knees and ankles are tight), FALL (Fell out of the sofa onto the floor) and MOBILITY DECREASED (Had to crawled because I couldn't lift myself up, was on the floor from Friday to Sunday) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 078C21A and 002C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (Patient was hospitalized.) in November 2020, Arm discomfort and Tooth extraction NOS (All the bottom teeth were pulled as she has jagged teeth underneath the bridge.) on 18-May-2021. Concurrent medical conditions included Blood disorder. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), GABAPENTIN and PARACETAMOL (TYLENOL) for an unknown indication. On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First shot on 15 May2021 and Second shot on 05 Aug2021), PERIPHERAL SWELLING (Right arm was swollen), ERYTHEMA (Right arm was red) and FATIGUE (Really tired). On 06-Aug-2021, the patient experienced ASTHENIA (Weakness), DIZZINESS (Dizziness, still dizzy), FALL (Fell out of the sofa onto the floor), MOBILITY DECREASED (Had to crawled because I couldn't lift myself up, was on the floor from Friday to Sunday) and DIARRHOEA (Diarrhea). In August 2021, the patient experienced MUSCLE TIGHTNESS (Muscles between the knees and ankles are tight), VERTIGO (Vertigo), MUSCULAR WEAKNESS (Weakness in legs) and VACCINATION SITE PAIN (It hurt when the needle entered). On 05-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First shot on 15 May2021 and Second shot on 05 Aug2021) had resolved. On 08-Aug-2021, DIARRHOEA (Diarrhea) had resolved. At the time of the report, ASTHENIA (Weakness) and DIZZINESS (Dizziness, still dizzy) had not resolved, MUSCLE TIGHTNESS (Muscles between the knees and ankles are tight), FALL (Fell out of the sofa onto the floor), MOBILITY DECREASED (Had to crawled because I couldn't lift myself up, was on the floor from Friday to Sunday), VERTIGO (Vertigo), MUSCULAR WEAKNESS (Weakness in legs), FATIGUE (Really tired) and VACCINATION SITE PAIN (It hurt when the needle entered) outcome was unknown and PERIPHERAL SWELLING (Right arm was swollen) and ERYTHEMA (Right arm was red) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Aug-2021, X-ray: normal (normal) normal. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient had spine condition which doesn't let her to put the hands in front of her body when she felled. Patient reported that the arm redness and swelling lasted until 3-4 days ago before reporting. Patient fell out of sofa on 06 Aug and found by neighbor on 08 Aug and was carried to hospital for 10 hours. Patient had a Brain scan, but the results were unknown. Patient was treated with Pills for diarrhea and blue liquid for diarrhea. Kneecap replacement surgery, shoulder surgery, and a cataracts surgery scheduled before was postponed due to the symptoms experienced after second dose of vaccination. This case was linked to MOD-2021-297455 (Patient Link).

Other Meds: SYNTHROID; GABAPENTIN; TYLENOL

Current Illness: Blood disorder

ID: 1691559
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant and treatment drugs were not provided

Other Meds:

Current Illness:

ID: 1691560
Sex: F
Age: 47
State: FL

Vax Date: 08/23/2021
Onset Date: 08/01/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Next day, she had really bad body aches.; She also had fatigue next day.; Within couple of hours, she had bad headache around left eye that went down to top of her jaw.; Within couple of hours, she had bad headache around left eye that went down to top of her jaw.; She slept for 23.5 hours; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (She slept for 23.5 hours), PAIN (Within couple of hours, she had bad headache around left eye that went down to top of her jaw.), PAIN (Next day, she had really bad body aches.), FATIGUE (She also had fatigue next day.) and HEADACHE (Within couple of hours, she had bad headache around left eye that went down to top of her jaw.) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040021A) for COVID-19 vaccination. Concomitant products included MONTELUKAST SODIUM (SINGULAIR), BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), BUSPIRONE HYDROCHLORIDE (BUSPAR) and FLUOXETINE for an unknown indication. On 23-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced HYPERSOMNIA (She slept for 23.5 hours). On 23-Aug-2021, the patient experienced PAIN (Within couple of hours, she had bad headache around left eye that went down to top of her jaw.) and HEADACHE (Within couple of hours, she had bad headache around left eye that went down to top of her jaw.). On 24-Aug-2021, the patient experienced PAIN (Next day, she had really bad body aches.) and FATIGUE (She also had fatigue next day.). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPERSOMNIA (She slept for 23.5 hours), PAIN (Within couple of hours, she had bad headache around left eye that went down to top of her jaw.), PAIN (Next day, she had really bad body aches.), FATIGUE (She also had fatigue next day.) and HEADACHE (Within couple of hours, she had bad headache around left eye that went down to top of her jaw.) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication included Blood pressure medicine. Patient had body aches. She also had fatigue. She slept for 23.5 hours and at the day of reporting she felt better.

Other Meds: SINGULAIR; SYMBICORT; BUSPAR; FLUOXETINE

Current Illness:

ID: 1691561
Sex: M
Age: 50
State: MA

Vax Date: 04/29/2021
Onset Date: 05/01/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Little more fatigued after second dose; 5-7 days after second dose atopic dermatitis was starting to go away/ after 10- 14 days the atopic dermatitis cleared up/ Now there is only a little tiny little bit left; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Little more fatigued after second dose) and DERMATITIS ATOPIC (5-7 days after second dose atopic dermatitis was starting to go away/ after 10- 14 days the atopic dermatitis cleared up/ Now there is only a little tiny little bit left) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination. Concurrent medical conditions included Atopic dermatitis, Eczema and Psoriasis (mainly on the palms of their hands, on the inside of their elbows, on the back of knee, in the lower back and in the inguinal area, and inner thigh.). On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, the patient experienced DERMATITIS ATOPIC (5-7 days after second dose atopic dermatitis was starting to go away/ after 10- 14 days the atopic dermatitis cleared up/ Now there is only a little tiny little bit left). On an unknown date, the patient experienced FATIGUE (Little more fatigued after second dose). At the time of the report, FATIGUE (Little more fatigued after second dose) and DERMATITIS ATOPIC (5-7 days after second dose atopic dermatitis was starting to go away/ after 10- 14 days the atopic dermatitis cleared up/ Now there is only a little tiny little bit left) outcome was unknown. The treatment history was not reported. The concomitant medication was not reported. The patient stated that after 5 to 7 days of receiving the second dose, there was an evidence that atopic dermatitis started to go away, and after about 10 to 14 days, his atopic dermatitis cleared up. Patient also stated that have not been cured of the atopic dermatitis. This case was linked to MOD-2021-297399 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: Follow up received on 30-AUG-2021, report contains patient demographics , facility information where vaccine given and outcom of event information were added.

Other Meds:

Current Illness: Atopic dermatitis; Eczema; Psoriasis (mainly on the palms of their hands, on the inside of their elbows, on the back of knee, in the lower back and in the inguinal area, and inner thigh.)

ID: 1691562
Sex: M
Age: 58
State: CA

Vax Date: 08/19/2021
Onset Date: 08/19/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: 2nd dose in April 3rd dose on 19AUG2021; 2" deep cut on the forehead after 3rd shot/Must have smashed my head on something; Tremendous pain in both arms after 3rd shot; Sick after 3rd shot; Tired after 3rd shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Tremendous pain in both arms after 3rd shot), HEAD INJURY (2" deep cut on the forehead after 3rd shot/Must have smashed my head on something), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose in April 3rd dose on 19AUG2021), ILLNESS (Sick after 3rd shot) and FATIGUE (Tired after 3rd shot) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017E21A) for COVID-19 vaccination. The patient's past medical history included Pneumonia and Cancer. On 19-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Aug-2021, the patient experienced PAIN IN EXTREMITY (Tremendous pain in both arms after 3rd shot), ILLNESS (Sick after 3rd shot) and FATIGUE (Tired after 3rd shot). On 20-Aug-2021, the patient experienced HEAD INJURY (2" deep cut on the forehead after 3rd shot/Must have smashed my head on something). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose in April 3rd dose on 19AUG2021). At the time of the report, PAIN IN EXTREMITY (Tremendous pain in both arms after 3rd shot), HEAD INJURY (2" deep cut on the forehead after 3rd shot/Must have smashed my head on something), ILLNESS (Sick after 3rd shot) and FATIGUE (Tired after 3rd shot) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose in April 3rd dose on 19AUG2021) had resolved. No concomitant medications reported. No treatment information was reported by reporter This case was linked to MOD-2021-297590, MOD-2021-297516 (Patient Link).

Other Meds:

Current Illness:

ID: 1691563
Sex: M
Age: 101
State: CA

Vax Date: 01/23/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: two weeks after first dose, right hand developed rheumatoid arthritis; very, very severe reaction; This spontaneous case was reported by a patient and describes the occurrence of RHEUMATOID ARTHRITIS (two weeks after first dose, right hand developed rheumatoid arthritis) in a 101-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced RHEUMATOID ARTHRITIS (two weeks after first dose, right hand developed rheumatoid arthritis) (seriousness criterion medically significant) and VACCINATION COMPLICATION (very, very severe reaction). At the time of the report, RHEUMATOID ARTHRITIS (two weeks after first dose, right hand developed rheumatoid arthritis) and VACCINATION COMPLICATION (very, very severe reaction) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant products were not provided. Treatment medication were not reported. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This case was linked to MOD-2021-297622 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 26-Aug-2021: Upon internal review on 07-Sep-2021: E2B Company Number was updated from US-irms-MOD21-135841 to US-MODERNATX, INC.-MOD-2021-297603; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1691564
Sex: F
Age: 31
State: KY

Vax Date: 08/17/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: hard red spot on the deltoid near the injection site about the size of a half dollar; hard red spot on the deltoid near the injection site about the size of a half dollar; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hard red spot on the deltoid near the injection site about the size of a half dollar) and VACCINATION SITE ERYTHEMA (hard red spot on the deltoid near the injection site about the size of a half dollar) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination. No Medical History information was reported. Concomitant products included VITAMINS NOS for an unknown indication. On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INDURATION (hard red spot on the deltoid near the injection site about the size of a half dollar) and VACCINATION SITE ERYTHEMA (hard red spot on the deltoid near the injection site about the size of a half dollar). At the time of the report, VACCINATION SITE INDURATION (hard red spot on the deltoid near the injection site about the size of a half dollar) and VACCINATION SITE ERYTHEMA (hard red spot on the deltoid near the injection site about the size of a half dollar) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information was provided. Patient had hard red spot and it was barely raised.

Other Meds: VITAMINS NOS

Current Illness:

ID: 1691565
Sex: F
Age: 37
State: AR

Vax Date: 08/25/2021
Onset Date: 08/25/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: A vial that has been opened for 9 days was administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A vial that has been opened for 9 days was administered) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (A vial that has been opened for 9 days was administered). On 25-Aug-2021, EXPIRED PRODUCT ADMINISTERED (A vial that has been opened for 9 days was administered) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product was not provided Treatment information was not provided CASE CROSSLINKED TO MOD21-135951, MOD21-135963

Other Meds:

Current Illness:

ID: 1691566
Sex: F
Age: 39
State: ME

Vax Date: 08/19/2021
Onset Date: 08/20/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: left armpit had fluid/left armpit felt like there was fluid there with lymph nodes; there is some pain; She can still feel it when she press on that spot/She had some pain with the initial injection/pain with the shot; bruise at the inoculation site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Aug-2021 and was forwarded to Moderna on 26-Aug-2021. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (bruise at the inoculation site), LYMPHADENOPATHY (left armpit had fluid/left armpit felt like there was fluid there with lymph nodes), LYMPH NODE PAIN (there is some pain) and VACCINATION SITE PAIN (She can still feel it when she press on that spot/She had some pain with the initial injection/pain with the shot) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On 19-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Aug-2021, the patient experienced VACCINATION SITE BRUISING (bruise at the inoculation site). On 25-Aug-2021, the patient experienced LYMPHADENOPATHY (left armpit had fluid/left armpit felt like there was fluid there with lymph nodes), LYMPH NODE PAIN (there is some pain) and VACCINATION SITE PAIN (She can still feel it when she press on that spot/She had some pain with the initial injection/pain with the shot). At the time of the report, VACCINATION SITE BRUISING (bruise at the inoculation site) had not resolved and LYMPHADENOPATHY (left armpit had fluid/left armpit felt like there was fluid there with lymph nodes), LYMPH NODE PAIN (there is some pain) and VACCINATION SITE PAIN (She can still feel it when she press on that spot/She had some pain with the initial injection/pain with the shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medications were reported. The day after receiving the vaccine she noticed that she had a bruise at the inoculation site. This has continued to today. Patient took an epsom salt bath yesterday and it helped with the pain. She can still feel it when she presses on that spot. She had some pain with the initial injection but that got better with moving it around.

Other Meds:

Current Illness:

ID: 1691567
Sex: F
Age:
State: WA

Vax Date: 01/02/2021
Onset Date: 01/04/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data: Test Date: 20210104; Test Name: pulmonay angiogram; Result Unstructured Data: PE, COVID and perocardiis ruled out by pulmonay angiogram

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: severe shortness of breath when exercising / Difficulty breathing; This spontaneous case was reported by a physician and describes the occurrence of DYSPNOEA (severe shortness of breath when exercising / Difficulty breathing) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The patient's past medical history included Hiatal hernia in 2018. Concurrent medical conditions included Anaphylaxis, Hypertension (BP was increasing for a few months before, in 2020) since 2000, Clotting disorder since 1999 and Heartburn. Concomitant products included OMEPRAZOLE from 2091 to an unknown date for Heartburn, HYDROCHLOROTHIAZIDE from 2001 to an unknown date and AMLODIPINE from 2017 to an unknown date for Hypertension. On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021 at 9:30 AM, the patient experienced DYSPNOEA (severe shortness of breath when exercising / Difficulty breathing). At the time of the report, DYSPNOEA (severe shortness of breath when exercising / Difficulty breathing) had resolved with sequelae. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jan-2021, Angiogram pulmonary: abnormal (abnormal) PE, COVID and perocardiis ruled out by pulmonay angiogram. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Lab tests include: ECG and Blood troponins. Patient stated that: Respirations >20 per min. Patient was sent to a cardiologist for increased BP management. Full workup to exclude infarct, studies included stress echo. Meds increased and BP was lowered, over a few weeks, but the dyspnoea did not improve. Treatment information was not provided. Event Recovered with residual effects - Reduced effort tolerance. Patient also asked about the booster dose. This case was linked to MOD-2021-297778 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: Reporter name,Patient demographics( height, weight, race, ethnic group), Patient's medical history, concomitant medications, date of start of event and outcome of the event were added.

Other Meds: HYDROCHLOROTHIAZIDE; AMLODIPINE; OMEPRAZOLE

Current Illness: Anaphylaxis; Clotting disorder; Heartburn; Hypertension (BP was increasing for a few months before, in 2020)

ID: 1691568
Sex: F
Age:
State: KS

Vax Date: 02/01/2021
Onset Date: 08/01/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Inappropriate schedule of vaccine administered; Fatigue; Muscle ache; Nausea; Vomiting; This spontaneous case was reported by a nurse and describes the occurrence of FATIGUE (Fatigue), MYALGIA (Muscle ache), NAUSEA (Nausea), VOMITING (Vomiting) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced FATIGUE (Fatigue), MYALGIA (Muscle ache), NAUSEA (Nausea) and VOMITING (Vomiting). On 25-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). The patient was treated with PARACETAMOL (TYLENOL) in August 2021 for Adverse event, at an unspecified dose and frequency. On 25-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, FATIGUE (Fatigue), MYALGIA (Muscle ache), NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. Vaccine facility information also included , . This case was linked to MOD-2021-297814 (Patient Link).

Other Meds:

Current Illness:

ID: 1691569
Sex: F
Age:
State: NY

Vax Date: 01/01/2021
Onset Date: 08/16/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: COVID-19 antibody test; Test Result: Negative ; Result Unstructured Data: Negative

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: itching; swelling; big reaction; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), SWELLING (swelling) and VACCINATION COMPLICATION (big reaction) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination. No Medical History information was reported. In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Aug-2021, the patient experienced PRURITUS (itching), SWELLING (swelling) and VACCINATION COMPLICATION (big reaction). At the time of the report, PRURITUS (itching) and SWELLING (swelling) had resolved and VACCINATION COMPLICATION (big reaction) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: negative (Negative) Negative. No concomitant medications were provided by reporter. No treatment medications were provided by reporter. This case was linked to MOD-2021-229580 (Patient Link).

Other Meds:

Current Illness:

ID: 1691570
Sex: F
Age: 65
State: NM

Vax Date: 07/28/2021
Onset Date: 08/25/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Bruised left arm; Swollen left arm; Burning feeling down left arm; Hot left arm; Very tired/ Fatigued; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruised left arm), PERIPHERAL SWELLING (Swollen left arm), BURNING SENSATION (Burning feeling down left arm), INJECTION SITE WARMTH (Hot left arm) and FATIGUE (Very tired/ Fatigued) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004F21A and 088021A) for COVID-19 vaccination. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Aug-2021, the patient experienced CONTUSION (Bruised left arm), PERIPHERAL SWELLING (Swollen left arm), BURNING SENSATION (Burning feeling down left arm), INJECTION SITE WARMTH (Hot left arm) and FATIGUE (Very tired/ Fatigued). At the time of the report, CONTUSION (Bruised left arm), PERIPHERAL SWELLING (Swollen left arm), BURNING SENSATION (Burning feeling down left arm), INJECTION SITE WARMTH (Hot left arm) and FATIGUE (Very tired/ Fatigued) outcome was unknown. Relevant concomitant medications includes antibiotics for UTI and severe sinus infections with double ear infections and take calcium and vitamin D for my bones. Treatment product information was not provided. This case was linked to MOD-2021-297880 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: Significant follow up received on 30-AUG-2021 and date of second dose of vaccine, concomitant medications and events has been updated.

Other Meds:

Current Illness:

ID: 1691571
Sex: M
Age: 51
State: CA

Vax Date: 05/07/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: ultrasound; Test Result: Negative ; Result Unstructured Data: Patient authorized an ultrasound which came back negative for anything cancerous/tumor.

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Low grade pain; Sore above it and below it; little bump underneath left armpit area; Lipoma (fatty cyst); This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Low grade pain), PAIN IN EXTREMITY (Sore above it and below it), AXILLARY PAIN (little bump underneath left armpit area) and LIPOMA (Lipoma (fatty cyst)) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049C21A and 025C21A) for COVID-19 vaccination. No Medical History information was reported. On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Low grade pain), PAIN IN EXTREMITY (Sore above it and below it), AXILLARY PAIN (little bump underneath left armpit area) and LIPOMA (Lipoma (fatty cyst)). At the time of the report, PAIN (Low grade pain), PAIN IN EXTREMITY (Sore above it and below it), AXILLARY PAIN (little bump underneath left armpit area) and LIPOMA (Lipoma (fatty cyst)) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: normal (Negative) Patient authorized an ultrasound which came back negative for anything cancerous/tumor.. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient experienced aggravated low grade pain and sore above it and below it when he works out. Patient tried physical therapy, massages, ice and heat to treat the pain. Treatment product information was not provided. Concomitant product use was not provided.

Other Meds:

Current Illness:

ID: 1691572
Sex: F
Age: 65
State: NM

Vax Date: 07/28/2021
Onset Date: 07/28/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Soreness in left arm; Very tired, fatigued; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness in left arm) and FATIGUE (Very tired, fatigued) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088021A) for COVID-19 vaccination. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced VACCINATION SITE PAIN (Soreness in left arm) and FATIGUE (Very tired, fatigued). On 28-Jul-2021, VACCINATION SITE PAIN (Soreness in left arm) had resolved. At the time of the report, FATIGUE (Very tired, fatigued) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Concomitant medications were not reported by reporter. Treatment information were not reported by reporter. This case was linked to MOD-2021-297855 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: Follow up received contains Non significant information.

Other Meds:

Current Illness:

ID: 1691573
Sex: U
Age:
State: NC

Vax Date: 08/17/2021
Onset Date: 08/24/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: started to experience a lot of side effects; Feeling under the weather.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (started to experience a lot of side effects) and MALAISE (Feeling under the weather.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Aug-2021, the patient experienced VACCINATION COMPLICATION (started to experience a lot of side effects) and MALAISE (Feeling under the weather.). At the time of the report, VACCINATION COMPLICATION (started to experience a lot of side effects) and MALAISE (Feeling under the weather.) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications were not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1691574
Sex: F
Age:
State: FL

Vax Date: 08/26/2021
Onset Date: 08/26/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of shortened coagulation time (blood hasn't clotted this quickly before) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 053E21A) for COVID-19 immunization. No medical history reported. On Aug 26, 2021 at 10:25 am, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Aug 26, 2021, patient experienced shortened coagulation time (blood hasn't clotted this quickly before). At the time of the report, shortened coagulation time (blood hasn't clotted this quickly before) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant medications and treatment information not reported. Patient reported she never experienced a blood clot so quickly before.

Other Meds:

Current Illness:

ID: 1691575
Sex: M
Age: 57
State: CA

Vax Date: 04/01/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Feeling hot; Sleep disturbance; Sickness; Bone pain; Felt faint; Decreased appetite; Weight loss; Myalgia; all the food made me sick; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Feeling hot), SLEEP DISORDER (Sleep disturbance), ILLNESS (Sickness), BONE PAIN (Bone pain) and DIZZINESS (Felt faint) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included INSULIN for an unknown indication. In April 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Feeling hot), SLEEP DISORDER (Sleep disturbance), ILLNESS (Sickness), BONE PAIN (Bone pain), DIZZINESS (Felt faint), DECREASED APPETITE (Decreased appetite), WEIGHT DECREASED (Weight loss), MYALGIA (Myalgia) and ILLNESS (all the food made me sick). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, FEELING HOT (Feeling hot), SLEEP DISORDER (Sleep disturbance), ILLNESS (Sickness), BONE PAIN (Bone pain), DIZZINESS (Felt faint), DECREASED APPETITE (Decreased appetite), WEIGHT DECREASED (Weight loss) and MYALGIA (Myalgia) outcome was unknown.

Other Meds: INSULIN

Current Illness:

ID: 1691576
Sex: F
Age: 82
State: NC

Vax Date: 02/01/2021
Onset Date: 08/26/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Pt received Pfizer as booster dose instead of Moderna; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Pt received Pfizer as booster dose instead of Moderna) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination. No Medical History information was reported. In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Aug-2021, the patient received third dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Aug-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Pt received Pfizer as booster dose instead of Moderna). On 26-Aug-2021, INTERCHANGE OF VACCINE PRODUCTS (Pt received Pfizer as booster dose instead of Moderna) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1691577
Sex: F
Age: 66
State: NY

Vax Date: 08/17/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: rash feels warm to the touch; big bullseye rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (rash feels warm to the touch) and VACCINATION SITE RASH (big bullseye rash at injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination. No Medical History information was reported. On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (rash feels warm to the touch) and VACCINATION SITE RASH (big bullseye rash at injection site). At the time of the report, VACCINATION SITE WARMTH (rash feels warm to the touch) and VACCINATION SITE RASH (big bullseye rash at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The concomitant history was not reported. The treatment history was not provided. Patient also reported events like "does not hurt", "is in her left arm". This case was linked to MOD-2021-298374 (Patient Link).

Other Meds:

Current Illness:

ID: 1691578
Sex: U
Age:
State: MA

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: never got the second dose since than; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (never got the second dose since than) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (never got the second dose since than). At the time of the report, PRODUCT DOSE OMISSION ISSUE (never got the second dose since than) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not reported. Treatment medications were not reported.

Other Meds:

Current Illness:

ID: 1691579
Sex: M
Age:
State: MD

Vax Date: 08/26/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Tested negative for coronavirus antibodies immediately prior to the first Pfizer dose; Test Result: Negative ; Result Unstructured Data: tested negative for coronavirus antibodies immediately prior to the first Pfizer dose

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Received a Moderna coronavirus vaccine "1st dose" today exactly 4 months after completing a Pfizer coronavirus vaccine regimen; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Received a Moderna coronavirus vaccine "1st dose" today exactly 4 months after completing a Pfizer coronavirus vaccine regimen) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination. Concurrent medical conditions included Asthma, Hypertension, Hypercholesterolemia and Obesity (BMI 30.5). On 26-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Received a Moderna coronavirus vaccine "1st dose" today exactly 4 months after completing a Pfizer coronavirus vaccine regimen). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Received a Moderna coronavirus vaccine "1st dose" today exactly 4 months after completing a Pfizer coronavirus vaccine regimen) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: negative (Negative) tested negative for coronavirus antibodies immediately prior to the first Pfizer dose. No concomitant medications provided. No treatment medications provided. Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: Follow up contains no new information.

Other Meds:

Current Illness: Asthma; Hypercholesterolemia; Hypertension; Obesity (BMI 30.5)

ID: 1691580
Sex: M
Age: 65
State: NY

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: very mild symptoms; mild soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (very mild symptoms) and MYALGIA (mild soreness in the arm) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. Concomitant products included FISH OIL for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (very mild symptoms) and MYALGIA (mild soreness in the arm). At the time of the report, VACCINATION COMPLICATION (very mild symptoms) and MYALGIA (mild soreness in the arm) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No Treatment medications was provided. This case was linked to MOD-2021-298226 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 31-Aug-2021: Follow up received and contains no new information regarding 1st Dose.

Other Meds: FISH OIL

Current Illness:

ID: 1691581
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of pyrexia (slight fever 5 days after vaccination) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pyrexia (slight fever 5 days after vaccination). At the time of the report, pyrexia (slight fever 5 days after vaccination) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications or treatment information reported.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am